Third Of Approved Drugs Need Safety Follow-Up, Study Finds

Law360, New York (May 9, 2017, 3:00 PM EDT) -- About a third of drugs approved by the U.S. Food and Drug Administration end up having additional safety concerns, Yale University researchers found in a study published Tuesday by the Journal of the American Medical Association.

Thirty-two percent of new drugs approved between 2001 and 2010 had some kind of safety issue detected by 2017, the university said in a news release. For the most part, those concerns were not severe enough to require the drugs to be pulled from the market, instead requiring a black-box warning or a safety communication from the agency.

The researchers called for the FDA to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!